Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Fla.
Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Fla.
Am J Med. 2019 Sep;132(9):1038-1043. doi: 10.1016/j.amjmed.2019.02.024. Epub 2019 Mar 7.
In 2018, the US Food and Drug Administration approved 59 novel drugs. This all-time record was due primarily to the expedited review pathways; 43 of the 59 (73%) novel drug approvals were designated in an expedited review pathway, and 34 of the 59 (58%) were approved for treatment of rare diseases. A review of these novel drugs is summarized.
2018 年,美国食品和药物管理局批准了 59 种新的药物。这一创纪录的数字主要得益于加速审查途径;59 种新批准药物中的 43 种(73%)被指定为加速审查途径,其中 34 种(58%)用于治疗罕见疾病。本文对这些新药进行了综述。